New research suggests GLP-1 weight-loss drugs like Ozempic and Zepbound may reduce cravings for alcohol and drugs by ...
Scientists are uncovering how GLP-1 drugs like Ozempic and Wegovy act on brain regions that control hunger, nausea, pleasure-based eating, and thirst. These discoveries may help create treatments that ...
When Susan Akin first started injecting a coveted weight-loss drug early this year, the chaos in her brain quieted. The ...
The heart benefits of semaglutide, the active ingredient in drugs such as Wegovy and Ozempic, do not depend on how much weight a person loses ...
Tribune Content Agency on MSN
Medicare to cover obesity drugs under Trump deal for as little as $50
The White House recently announced a landmark deal with pharmaceutical companies Eli Lilly and Nordisk that will impact ...
Key Takeaways With Medicare open enrollment underway, you can shop for and switch to a more affordable 2026 plan until Dec. 7. You can also save by applying for assistance programs, checking drug ...
Robert Armstrong There has been a wild and hectic series of M&A deals in the pharmaceuticals industry. We are now headed for ...
Eli Lilly and Company, Novo Nordisk A/S Class B, Novo Nordisk A/S Class B, Novo Nordisk B. Read The Tokenist (Timothy Fries)'s latest article on Investing.com Canada.
Eli Lilly India chief Winselow Tucker said the companys strategy of combining a strong product with ecosystem partnerships and patient education has helped drive early momentum for Mounjaro in India, ...
Viking Therapeutics, Inc. (Viking) , a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced the completion of ...
The new generation of obesity medications are inducing greater weight loss than any prior pharmacotherapy. There is discussion now about how to support fat loss while protecting lean mass.“Lean mass ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results